News

Two rival medical device companies specialising in scalp cooling technologies for cancer patients are merging to form a ...
LumiThera has released new topline data for its Valeda Light Delivery System to slow the progression of dry age-related ...
GeneDx has completed the acquisition of Fabric Genomics, a US-based company focused on AI-driven human genomic interpretation ...
The National Institutes of Health (NIH) and the Centers for Medicare & Medicaid Services (CMS) are partnering to develop a ...
Eye health company Bausch + Lomb has received the CE Mark approval in Europe for its LuxLife full range of vision intraocular ...
HeartBeam has secured two new US patents, strengthening its intellectual property (IP) portfolio in cardiac monitoring ...
Endogenex has shared results from its REGENT-1 clinical study during the Digestive Disease Week (DDW) 2025 event held in San ...
MedTech reveals that Europeans are generally willing to share their healthcare data in exchange for personalised treatment ...
The company slashed its 2025 earnings forecast due to the ongoing financial fallout from the US-China tariffs.
URA has entered the consumer diabetes space, offering a new glucose feature for its ring that uses insights from Dexcom’s CGM ...
Natera has announced findings from a study evaluating its Signatera in individuals with soft tissue and bone sarcomas.
The Final Rule was mooted for implementation over a staged transition period, determined by a service’s risk level, by 2028.